Woodline Partners LP Kal Vista Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

$17.6 Billion
Q2 2025

A detailed history of Woodline Partners LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,920,664 shares of KALV stock, worth $23.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,920,664

Previous 1,617,469 18.75%

Holding current value

$23.5 Million

Previous $18.7 Million 16.38%

% of portfolio

0.12%

Previous 0.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$10.32 - $14.76 $3.13 Million - $4.48 Million	303,195 Added 18.75%	1,920,664 $21.7 Million
Q1 2025 May 15, 2025	BUY	$7.4 - $12.6 $2.44 Million - $4.15 Million	329,068 Added 25.54%	1,617,469 $18.7 Million
Q4 2024 Feb 14, 2025	BUY	$8.09 - $12.5 $5.5 Million - $8.5 Million	680,148 Added 111.82%	1,288,401 $10.9 Million
Q3 2024 Nov 14, 2024	BUY	$9.46 - $15.39 $4.33 Million - $7.05 Million	457,791 Added 304.26%	608,253 $7.04 Million
Q1 2024 May 15, 2024	SELL	$11.07 - $16.04 $2.17 Million - $3.15 Million	-196,401 Reduced 56.62%	150,462 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $2.63 Million - $4.25 Million	346,863 New	346,863 $4.25 Million
Q2 2023 Aug 14, 2023	BUY	$7.73 - $10.57 $837,607 - $1.15 Million	108,358 New	108,358 $975,000
Q4 2022 Feb 14, 2023	SELL	$4.2 - $14.24 $668,098 - $2.27 Million	-159,071 Reduced 21.13%	593,810 $4.01 Million
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $3.29 Million - $5.62 Million	-334,002 Reduced 30.73%	752,881 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $4.81 Million - $8.91 Million	589,869 Added 118.68%	1,086,883 $10.7 Million
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $4.01 Million - $6.08 Million	358,276 Added 258.24%	497,014 $7.33 Million
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $116,023 - $171,594	9,387 Added 7.26%	138,738 $1.84 Million
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $473,005 - $677,026	27,645 Added 27.18%	129,351 $2.26 Million
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $2.83 Million - $3.66 Million	-122,353 Reduced 54.61%	101,706 $2.44 Million
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $3.29 Million - $9.54 Million	224,059 New	224,059 $5.76 Million

Others Institutions Holding KALV

# of Institutions

149

Shares Held

54.3M

Call Options Held

1.07M

Put Options Held

90.1K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $301M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Kal Vista Pharmaceuticals, Inc. Transaction History